HBIO HARVARD BIOSCIENCE INC: institutional ownership and insider trading

35 funds reported holding $8.84M of HARVARD BIOSCIENCE INC in their latest 13F filings; in Q2 2026 funds net bought $23.5K, with 4 new positions and 2 funds selling out; over the last 12 months insiders bought $202K and sold $0 on the open market; over its last four quarters it reported revenue of $87.8M and net income of −$10.4M.

HBIO revenue and earnings

Famous investors holding HBIO

Largest institutional holders of HBIO

  1. WEBER CAPITAL MANAGEMENT LLC /ADV — $2.37M
  2. ACADIAN ASSET MANAGEMENT LLC — $1.10M
  3. VANGUARD CAPITAL MANAGEMENT LLC — $1.04M
  4. CORSAIR CAPITAL MANAGEMENT, L.P. — $755K
  5. TWO SIGMA INVESTMENTS, LP — $704K
  6. RENAISSANCE TECHNOLOGIES LLC — $611K
  7. BlackRock, Inc. (BLK) — $380K
  8. GEODE CAPITAL MANAGEMENT, LLC — $293K
  9. ESSEX INVESTMENT MANAGEMENT CO LLC — $214K
  10. Mink Brook Asset Management LLC — $205K

Recent HBIO insider trades

5%+ owners

Who owns the most HBIO stock?

The largest institutional holders of HARVARD BIOSCIENCE INC in the latest 13F filings are WEBER CAPITAL MANAGEMENT LLC /ADV ($2.37M), ACADIAN ASSET MANAGEMENT LLC ($1.10M), VANGUARD CAPITAL MANAGEMENT LLC ($1.04M).

Are insiders buying or selling HBIO?

Over the last 12 months insiders bought $202K and sold $0 of HARVARD BIOSCIENCE INC stock on the open market (SEC Form 4).

Which famous investors own HBIO?

Two Sigma, Renaissance Technologies, Izzy Englander, Ken Griffin.

What was HBIO's revenue last quarter?

HARVARD BIOSCIENCE INC reported revenue of $22.7M for the quarter ended June 30, 2026, with net income of −$2.91M.

All HBIO 13F holders · All HBIO insider trades